Literature DB >> 29091770

The mTORC1 Signaling Network Senses Changes in Cellular Purine Nucleotide Levels.

Gerta Hoxhaj1, James Hughes-Hallett1, Rebecca C Timson1, Erika Ilagan1, Min Yuan2, John M Asara2, Issam Ben-Sahra3, Brendan D Manning4.   

Abstract

Mechanistic (or mammalian) target of rapamycin complex 1 (mTORC1) integrates signals from growth factors and nutrients to control biosynthetic processes, including protein, lipid, and nucleic acid synthesis. We find that the mTORC1 pathway is responsive to changes in purine nucleotides in a manner analogous to its sensing of amino acids. Depletion of cellular purines, but not pyrimidines, inhibits mTORC1, and restoration of intracellular adenine nucleotides via addition of exogenous purine nucleobases or nucleosides acutely reactivates mTORC1. Adenylate sensing by mTORC1 is dependent on the tuberous sclerosis complex (TSC) protein complex and its regulation of Rheb upstream of mTORC1, but independent of energy stress and AMP-activated protein kinase (AMPK). Even though mTORC1 signaling is not acutely sensitive to changes in intracellular guanylates, long-term depletion of guanylates decreases Rheb protein levels. Our findings suggest that nucleotide sensing, like amino acid sensing, enables mTORC1 to tightly coordinate nutrient availability with the synthesis of macromolecules, such as protein and nucleic acids, produced from those nutrients.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMPK; ATP; GTP; Rag GTPases; Rheb; mTOR; nucleotides; nutrient sensing; purine; tuberous sclerosis complex

Mesh:

Substances:

Year:  2017        PMID: 29091770      PMCID: PMC5689476          DOI: 10.1016/j.celrep.2017.10.029

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  35 in total

1.  mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle.

Authors:  Issam Ben-Sahra; Gerta Hoxhaj; Stéphane J H Ricoult; John M Asara; Brendan D Manning
Journal:  Science       Date:  2016-02-12       Impact factor: 47.728

2.  Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.

Authors:  K Hara; K Yonezawa; Q P Weng; M T Kozlowski; C Belham; J Avruch
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

Review 3.  AMPK: a nutrient and energy sensor that maintains energy homeostasis.

Authors:  D Grahame Hardie; Fiona A Ross; Simon A Hawley
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-22       Impact factor: 94.444

4.  Mammalian TOR: a homeostatic ATP sensor.

Authors:  P B Dennis; A Jaeschke; M Saitoh; B Fowler; S C Kozma; G Thomas
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

Review 5.  AMPK--sensing energy while talking to other signaling pathways.

Authors:  D Grahame Hardie
Journal:  Cell Metab       Date:  2014-10-30       Impact factor: 27.287

Review 6.  Timeline: Chemotherapy and the war on cancer.

Authors:  Bruce A Chabner; Thomas G Roberts
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

7.  Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome.

Authors:  Suchithra Menon; Christian C Dibble; George Talbott; Gerta Hoxhaj; Alexander J Valvezan; Hidenori Takahashi; Lewis C Cantley; Brendan D Manning
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

8.  Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis.

Authors:  Aaron M Robitaille; Stefan Christen; Mitsugu Shimobayashi; Marion Cornu; Luca L Fava; Suzette Moes; Cristina Prescianotto-Baschong; Uwe Sauer; Paul Jenoe; Michael N Hall
Journal:  Science       Date:  2013-02-21       Impact factor: 47.728

9.  Regulation of TORC1 by Rag GTPases in nutrient response.

Authors:  Eunjung Kim; Pankuri Goraksha-Hicks; Li Li; Thomas P Neufeld; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

10.  AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation.

Authors:  Graeme J Gowans; Simon A Hawley; Fiona A Ross; D Grahame Hardie
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

View more
  59 in total

1.  T cell activation triggers reversible inosine-5'-monophosphate dehydrogenase assembly.

Authors:  Krisna C Duong-Ly; Yin-Ming Kuo; Matthew C Johnson; Joy M Cote; Justin M Kollman; Jonathan Soboloff; Glenn F Rall; Andrew J Andrews; Jeffrey R Peterson
Journal:  J Cell Sci       Date:  2018-09-05       Impact factor: 5.285

2.  Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-d]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism.

Authors:  Aamod S Dekhne; Changwen Ning; Md Junayed Nayeen; Khushbu Shah; Hasini Kalpage; Josephine Frühauf; Adrianne Wallace-Povirk; Carrie O'Connor; Zhanjun Hou; Seongho Kim; Maik Hüttemann; Aleem Gangjee; Larry H Matherly
Journal:  Mol Pharmacol       Date:  2019-11-09       Impact factor: 4.436

3.  IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.

Authors:  Alexander J Valvezan; Molly C McNamara; Spencer K Miller; Margaret E Torrence; John M Asara; Elizabeth P Henske; Brendan D Manning
Journal:  JCI Insight       Date:  2020-04-09

Review 4.  Nutrient regulation of mTORC1 at a glance.

Authors:  Kendall J Condon; David M Sabatini
Journal:  J Cell Sci       Date:  2019-11-13       Impact factor: 5.285

Review 5.  The Lysosome at the Intersection of Cellular Growth and Destruction.

Authors:  Hijai R Shin; Roberto Zoncu
Journal:  Dev Cell       Date:  2020-06-30       Impact factor: 12.270

6.  Glycolysis-Independent Glucose Metabolism Distinguishes TE from ICM Fate during Mammalian Embryogenesis.

Authors:  Fangtao Chi; Mark S Sharpley; Raghavendra Nagaraj; Shubhendu Sen Roy; Utpal Banerjee
Journal:  Dev Cell       Date:  2020-03-19       Impact factor: 12.270

7.  Metabolomic studies identify changes in transmethylation and polyamine metabolism in a brain-specific mouse model of tuberous sclerosis complex.

Authors:  James McKenna; David Kapfhamer; Jason M Kinchen; Brandi Wasek; Matthew Dunworth; Tracy Murray-Stewart; Teodoro Bottiglieri; Robert A Casero; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2018-06-15       Impact factor: 6.150

8.  Nitrogen Trapping as a Therapeutic Strategy in Tumors with Mitochondrial Dysfunction.

Authors:  Hanumantha Rao Madala; Iiro Taneli Helenius; Wen Zhou; Evanna Mills; Yiyun Zhang; Yan Liu; Ana M Metelo; Michelle L Kelley; Surendra Punganuru; Kyung Bo Kim; Benjamin Olenchock; Eugene Rhee; Andrew M Intlekofer; Othon Iliopoulos; Edward Chouchani; Jing-Ruey Joanna Yeh
Journal:  Cancer Res       Date:  2020-07-10       Impact factor: 12.701

Review 9.  mTOR at the nexus of nutrition, growth, ageing and disease.

Authors:  Grace Y Liu; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2020-01-14       Impact factor: 94.444

Review 10.  Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer.

Authors:  Aamod S Dekhne; Zhanjun Hou; Aleem Gangjee; Larry H Matherly
Journal:  Mol Cancer Ther       Date:  2020-09-02       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.